Orthopaedisches Spital Speising GmbH

The Orthopaedisches Spital Speising GmbH conducts research in hip arthroplasty within a fast‑track protocol that emphasizes early mobilization and brief hospital stay, aiming to test whether a shortened course of direct oral anticoagulant therapy is as effective as the traditional longer regimen in preventing blood clots.

• Reduced duration of postoperative thromboprophylaxis
• Early patient discharge after surgery
• Comparison of safety outcomes with standard anticoagulation

This work supports the hospital’s commitment to enhancing recovery pathways for patients undergoing elective primary hip replacement in Vienna.

At the same site, investigators explore innovative solutions for patellofemoral osteoarthritis by implanting tissue‑engineered nasal cartilage (N‑TEC) and measuring improvement with the KOOS‑5 score, seeking a superior clinical outcome compared with current standard procedures.

• Regenerative approach to knee joint cartilage
• Long‑term functional assessment over two years
• Evaluation against established microfracture technique

The trial reflects the hospital’s focus on advancing musculoskeletal therapies and offering patients cutting‑edge treatment options.